DSP Trustee Private Limited on behalf of schemes of DSP Mutual Fund
Cohance Lifesciences Limited · NSE
−28,99,996 sh
Jusmiral Holdings Limited
Investor
₹3,093.81 Cr
5,82,42,578 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
3.9% of their portfolio
₹266.37 Cr
62,66,692 sh
SBI Multi Asset Allocation Fund
1.1% of their portfolio
₹221.03 Cr
52,00,000 sh
HDFC Mutual Fund (scheme HDFCGR)
16.0% of their portfolio
₹176.12 Cr
41,43,548 sh
SBI Balanced Advantage Fund
30.0% of their portfolio
₹127.52 Cr
30,00,000 sh
ICICI Prudential India Opportunities Fund
0.3% of their portfolio
₹101.05 Cr
23,77,398 sh
ICICI Prudential Value Fund
0.2% of their portfolio
₹97.82 Cr
23,01,367 sh
ICICI Prudential Equity & Debt Fund
0.2% of their portfolio
₹94.12 Cr
22,14,332 sh
SBI Healthcare Opportunities Fund
1.7% of their portfolio
₹93.51 Cr
22,00,000 sh
SBI MNC Fund
1.4% of their portfolio
₹93.51 Cr
22,00,000 sh
ICICI Prudential Innovation Fund
1.1% of their portfolio
₹88.73 Cr
20,87,442 sh
HDFC ELSS Tax saver
38.0% of their portfolio
₹60.57 Cr
14,25,000 sh
FIIs raised their stake +0.9pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
DSP Trustee Private Limited on behalf of schemes of DSP Mutual Fund
Cohance Lifesciences Limited · NSE
−28,99,996 sh
Groww Mutual Fund (scheme XC)
Cohance Lifesciences Limited · NSE
1,229 sh · ₹5.22 L
ICICI Prudential MNC Fund
Cohance Lifesciences Limited · NSE
4,70,757 sh · ₹20.01 Cr
HDFC Pharma and Healthcare Fund
Cohance Lifesciences Limited · NSE
2,50,000 sh · ₹10.63 Cr
HDFC Large and Mid Cap Fund
Cohance Lifesciences Limited · NSE
12,72,428 sh · ₹54.08 Cr
Nippon India Nifty Smallcap 250 Index Fund
Cohance Lifesciences Limited · NSE
2,56,166 sh · ₹10.89 Cr
SBI Healthcare Opportunities Fund
Cohance Lifesciences Limited · NSE
22,00,000 sh · ₹93.51 Cr
SBI Balanced Advantage Fund
Cohance Lifesciences Limited · NSE
30,00,000 sh · ₹127.52 Cr
HDFC Nifty Smallcap 250 Index Fund
Cohance Lifesciences Limited · NSE
55,002 sh · ₹2.34 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
15 announcements on record for this company.
Promoter holding by quarter: Jun 2025 66.4%, Sep 2025 57.5%, Dec 2025 57.5%, Mar 2026 57.5%. Dec 2024, Mar 2025: no filing.
FII
— −0.4pp
FII holding by quarter: Jun 2025 7.2%, Sep 2025 6.5%, Dec 2025 6.0%, Mar 2026 5.6%. Dec 2024, Mar 2025: no filing.
DII
— +0.2pp
DII holding by quarter: Jun 2025 11.4%, Sep 2025 20.8%, Dec 2025 21.6%, Mar 2026 21.8%. Dec 2024, Mar 2025: no filing.
MF
— +1.2pp
MF holding by quarter: Jun 2025 8.9%, Sep 2025 16.5%, Dec 2025 17.4%, Mar 2026 18.6%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
SBI MNC Fund
Cohance Lifesciences Limited · NSE
22,00,000 sh · ₹93.51 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 66.4%, Sep 2025 57.5%, Dec 2025 57.5%, Mar 2026 57.5%. Dec 2024, Mar 2025: no filing.
FII
— −0.4pp
FII holding by quarter: Jun 2025 7.2%, Sep 2025 6.5%, Dec 2025 6.0%, Mar 2026 5.6%. Dec 2024, Mar 2025: no filing.
DII
— +0.2pp
DII holding by quarter: Jun 2025 11.4%, Sep 2025 20.8%, Dec 2025 21.6%, Mar 2026 21.8%. Dec 2024, Mar 2025: no filing.
MF
— +1.2pp
MF holding by quarter: Jun 2025 8.9%, Sep 2025 16.5%, Dec 2025 17.4%, Mar 2026 18.6%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
15 announcements on record for this company.